Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 11 | 2020 | 409 | 1.220 |
Why?
|
Drug Resistance, Neoplasm | 5 | 2020 | 63 | 0.790 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2016 | 42 | 0.780 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2012 | 20 | 0.760 |
Why?
|
Epithelial Cells | 7 | 2018 | 84 | 0.720 |
Why?
|
Cell Proliferation | 10 | 2020 | 178 | 0.600 |
Why?
|
Estrogen Receptor alpha | 3 | 2012 | 15 | 0.580 |
Why?
|
Cytostatic Agents | 1 | 2016 | 2 | 0.520 |
Why?
|
Mutation | 7 | 2021 | 353 | 0.510 |
Why?
|
Lithium | 6 | 2005 | 19 | 0.500 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2020 | 112 | 0.490 |
Why?
|
Aspirin | 1 | 2016 | 84 | 0.480 |
Why?
|
Breast | 4 | 2011 | 26 | 0.460 |
Why?
|
Tamoxifen | 2 | 2014 | 28 | 0.410 |
Why?
|
Cell Line, Tumor | 12 | 2020 | 249 | 0.400 |
Why?
|
Magnesium | 4 | 2004 | 36 | 0.330 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2018 | 30 | 0.330 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2018 | 21 | 0.310 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2008 | 8 | 0.300 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 190 | 0.290 |
Why?
|
MAP Kinase Signaling System | 3 | 2019 | 37 | 0.280 |
Why?
|
Phosphorylation | 5 | 2016 | 149 | 0.250 |
Why?
|
Neoplasms | 1 | 2008 | 239 | 0.250 |
Why?
|
Proto-Oncogene Proteins | 2 | 2017 | 35 | 0.240 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 281 | 0.230 |
Why?
|
Humans | 29 | 2021 | 28395 | 0.220 |
Why?
|
Trastuzumab | 2 | 2020 | 27 | 0.220 |
Why?
|
Membrane Proteins | 2 | 2020 | 171 | 0.220 |
Why?
|
Receptor, ErbB-2 | 2 | 2020 | 50 | 0.210 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 4 | 2016 | 9 | 0.200 |
Why?
|
Estrogens | 2 | 2014 | 24 | 0.180 |
Why?
|
Bipolar Disorder | 5 | 2004 | 132 | 0.180 |
Why?
|
Female | 15 | 2020 | 15704 | 0.180 |
Why?
|
STAT6 Transcription Factor | 1 | 2020 | 11 | 0.170 |
Why?
|
Neoadjuvant Therapy | 1 | 2020 | 66 | 0.170 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2020 | 17 | 0.170 |
Why?
|
Triple Negative Breast Neoplasms | 1 | 2020 | 17 | 0.170 |
Why?
|
Class Ia Phosphatidylinositol 3-Kinase | 1 | 2019 | 4 | 0.160 |
Why?
|
Receptors, Estrogen | 2 | 2017 | 60 | 0.160 |
Why?
|
Mice | 6 | 2020 | 1461 | 0.160 |
Why?
|
Protein Kinase Inhibitors | 1 | 2019 | 50 | 0.160 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2020 | 241 | 0.160 |
Why?
|
Animals | 8 | 2020 | 3780 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 244 | 0.150 |
Why?
|
Glycogen Synthase Kinase 3 beta | 2 | 2016 | 14 | 0.150 |
Why?
|
Ion Channels | 1 | 2020 | 234 | 0.150 |
Why?
|
Macrophages | 1 | 2018 | 108 | 0.140 |
Why?
|
Pancreatic Neoplasms | 1 | 2018 | 97 | 0.140 |
Why?
|
Lipid Metabolism | 1 | 2017 | 38 | 0.140 |
Why?
|
MCF-7 Cells | 1 | 2016 | 13 | 0.130 |
Why?
|
Lung Neoplasms | 1 | 2021 | 553 | 0.130 |
Why?
|
Gene Targeting | 3 | 2019 | 10 | 0.130 |
Why?
|
ras Proteins | 2 | 2013 | 10 | 0.120 |
Why?
|
Erythrocytes | 3 | 2004 | 20 | 0.120 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 274 | 0.120 |
Why?
|
Hydrolases | 1 | 2014 | 4 | 0.120 |
Why?
|
DNA Repair Enzymes | 1 | 2014 | 7 | 0.120 |
Why?
|
Ion Transport | 2 | 2003 | 31 | 0.110 |
Why?
|
Signal Transduction | 3 | 2019 | 447 | 0.110 |
Why?
|
Precancerous Conditions | 2 | 2018 | 25 | 0.100 |
Why?
|
Prognosis | 3 | 2014 | 825 | 0.100 |
Why?
|
Receptors, Androgen | 1 | 2012 | 6 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2019 | 50 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2011 | 2 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 4 | 2005 | 41 | 0.100 |
Why?
|
Genomic Instability | 1 | 2011 | 8 | 0.100 |
Why?
|
Genes, BRCA1 | 1 | 2011 | 12 | 0.100 |
Why?
|
Middle Aged | 7 | 2020 | 9250 | 0.090 |
Why?
|
Cell Cycle | 2 | 2008 | 34 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2009 | 82 | 0.090 |
Why?
|
Lithium Compounds | 1 | 2011 | 3 | 0.090 |
Why?
|
ErbB Receptors | 1 | 2011 | 54 | 0.090 |
Why?
|
RNA, Small Interfering | 3 | 2020 | 79 | 0.090 |
Why?
|
Gene Knockdown Techniques | 2 | 2020 | 45 | 0.080 |
Why?
|
Carcinoma, Small Cell | 1 | 2009 | 54 | 0.080 |
Why?
|
Oncogenes | 1 | 2009 | 11 | 0.080 |
Why?
|
Transcription, Genetic | 1 | 2009 | 106 | 0.080 |
Why?
|
Treatment Outcome | 3 | 2020 | 3615 | 0.080 |
Why?
|
Cell Cycle Proteins | 1 | 2008 | 16 | 0.080 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 138 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2008 | 79 | 0.070 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2007 | 4 | 0.070 |
Why?
|
Cell Membrane | 2 | 2005 | 90 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2009 | 147 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 120 | 0.070 |
Why?
|
Up-Regulation | 3 | 2017 | 177 | 0.070 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 59 | 0.070 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2007 | 4 | 0.070 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 104 | 0.070 |
Why?
|
Genes, ras | 1 | 2007 | 13 | 0.070 |
Why?
|
Multiple Myeloma | 1 | 2007 | 21 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2007 | 37 | 0.070 |
Why?
|
Mice, Knockout | 1 | 2008 | 316 | 0.070 |
Why?
|
Heterografts | 2 | 2020 | 15 | 0.070 |
Why?
|
Polymerase Chain Reaction | 1 | 2007 | 120 | 0.070 |
Why?
|
Intracellular Fluid | 2 | 2003 | 4 | 0.070 |
Why?
|
Neuroblastoma | 2 | 2003 | 19 | 0.070 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 119 | 0.070 |
Why?
|
RNA Interference | 3 | 2014 | 36 | 0.070 |
Why?
|
DNA Methylation | 1 | 2007 | 165 | 0.070 |
Why?
|
Response Elements | 1 | 2006 | 15 | 0.070 |
Why?
|
Mice, Nude | 3 | 2013 | 24 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2006 | 58 | 0.060 |
Why?
|
Estradiol | 1 | 2006 | 39 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2004 | 351 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2019 | 13 | 0.060 |
Why?
|
Biomarkers, Tumor | 2 | 2019 | 202 | 0.060 |
Why?
|
Transducin | 1 | 2004 | 1 | 0.060 |
Why?
|
Guanosine Diphosphate | 1 | 2004 | 3 | 0.060 |
Why?
|
Antimanic Agents | 1 | 2004 | 8 | 0.060 |
Why?
|
Cell Line | 3 | 2011 | 280 | 0.060 |
Why?
|
Chlorides | 1 | 2003 | 26 | 0.050 |
Why?
|
Glycine | 1 | 2003 | 12 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2003 | 269 | 0.050 |
Why?
|
Cobalt | 1 | 2003 | 113 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 13 | 0.050 |
Why?
|
Transgenes | 2 | 2014 | 14 | 0.050 |
Why?
|
Time Factors | 1 | 2006 | 1490 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2021 | 3 | 0.050 |
Why?
|
Pyridazines | 1 | 2021 | 2 | 0.050 |
Why?
|
Piperidines | 1 | 2021 | 12 | 0.050 |
Why?
|
Benzamides | 1 | 2021 | 15 | 0.050 |
Why?
|
Exons | 1 | 2021 | 33 | 0.050 |
Why?
|
Pyrimidines | 1 | 2021 | 22 | 0.050 |
Why?
|
Models, Biological | 1 | 2003 | 326 | 0.050 |
Why?
|
Triazines | 1 | 2021 | 12 | 0.050 |
Why?
|
Gene Knock-In Techniques | 2 | 2013 | 7 | 0.050 |
Why?
|
Phenotype | 2 | 2014 | 310 | 0.050 |
Why?
|
Hyaluronoglucosaminidase | 1 | 2020 | 2 | 0.050 |
Why?
|
Imidazoles | 1 | 2021 | 55 | 0.050 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 25 | 0.050 |
Why?
|
Drug Approval | 1 | 2020 | 7 | 0.050 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 22 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 51 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 81 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2012 | 28 | 0.040 |
Why?
|
Gene Expression | 2 | 2012 | 202 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 6 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2020 | 8 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2020 | 166 | 0.040 |
Why?
|
CRISPR-Cas Systems | 1 | 2020 | 10 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2020 | 45 | 0.040 |
Why?
|
Cell Survival | 1 | 2020 | 120 | 0.040 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 94 | 0.040 |
Why?
|
NADPH Oxidases | 1 | 2020 | 55 | 0.040 |
Why?
|
Cell Movement | 1 | 2020 | 82 | 0.040 |
Why?
|
Biological Transport | 3 | 2004 | 40 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2020 | 362 | 0.040 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 102 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 329 | 0.040 |
Why?
|
RAW 264.7 Cells | 1 | 2018 | 3 | 0.040 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2018 | 11 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2018 | 30 | 0.040 |
Why?
|
Mice, SCID | 1 | 2018 | 45 | 0.040 |
Why?
|
Transplantation, Heterologous | 2 | 2009 | 20 | 0.040 |
Why?
|
Carcinogenesis | 1 | 2018 | 25 | 0.040 |
Why?
|
Adult | 3 | 2020 | 8097 | 0.040 |
Why?
|
Pancreas | 1 | 2018 | 33 | 0.040 |
Why?
|
Down-Regulation | 2 | 2009 | 102 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2019 | 371 | 0.040 |
Why?
|
Pre-B-Cell Leukemia Transcription Factor 1 | 1 | 2017 | 1 | 0.040 |
Why?
|
Alleles | 2 | 2007 | 221 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2019 | 619 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2017 | 308 | 0.030 |
Why?
|
Aged | 2 | 2020 | 9256 | 0.030 |
Why?
|
Gene Dosage | 1 | 2014 | 18 | 0.030 |
Why?
|
Phospholipids | 2 | 2005 | 10 | 0.030 |
Why?
|
Gene Deletion | 1 | 2014 | 42 | 0.030 |
Why?
|
Base Sequence | 1 | 2014 | 107 | 0.030 |
Why?
|
Isotopes | 2 | 2005 | 2 | 0.030 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 199 | 0.030 |
Why?
|
Binding, Competitive | 2 | 2004 | 24 | 0.030 |
Why?
|
United States | 1 | 2020 | 2196 | 0.030 |
Why?
|
Epigenesis, Genetic | 1 | 2014 | 86 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2013 | 1 | 0.030 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2013 | 2 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 5 | 0.030 |
Why?
|
Point Mutation | 1 | 2013 | 27 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2013 | 46 | 0.030 |
Why?
|
Metribolone | 1 | 2012 | 1 | 0.020 |
Why?
|
Tosyl Compounds | 1 | 2012 | 2 | 0.020 |
Why?
|
Cyclin D1 | 1 | 2012 | 5 | 0.020 |
Why?
|
Anilides | 1 | 2012 | 7 | 0.020 |
Why?
|
Androgens | 1 | 2012 | 8 | 0.020 |
Why?
|
Androgen Antagonists | 1 | 2012 | 5 | 0.020 |
Why?
|
Nitriles | 1 | 2012 | 14 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2012 | 120 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 25 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 34 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 15 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2012 | 213 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2011 | 7 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 33 | 0.020 |
Why?
|
Heterozygote | 1 | 2011 | 102 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2020 | 4851 | 0.020 |
Why?
|
Immunoblotting | 1 | 2011 | 57 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 284 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2009 | 15 | 0.020 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2009 | 10 | 0.020 |
Why?
|
Mammary Glands, Human | 1 | 2009 | 7 | 0.020 |
Why?
|
Protein Kinases | 1 | 2009 | 13 | 0.020 |
Why?
|
Biopsy | 1 | 2009 | 220 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2007 | 1 | 0.020 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2007 | 2 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2007 | 4 | 0.020 |
Why?
|
Translocation, Genetic | 1 | 2007 | 5 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 5 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2007 | 32 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 12 | 0.020 |
Why?
|
Telomerase | 1 | 2007 | 9 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2009 | 112 | 0.020 |
Why?
|
Mutagenesis | 1 | 2007 | 12 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2007 | 15 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 32 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 87 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2007 | 60 | 0.020 |
Why?
|
Phosphorus Isotopes | 1 | 2005 | 1 | 0.020 |
Why?
|
Binding Sites | 1 | 2005 | 75 | 0.020 |
Why?
|
Protein Binding | 1 | 2005 | 132 | 0.020 |
Why?
|
Male | 3 | 2009 | 15269 | 0.010 |
Why?
|
Rod Cell Outer Segment | 1 | 2004 | 1 | 0.010 |
Why?
|
Guanosine Triphosphate | 1 | 2004 | 4 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 2004 | 9 | 0.010 |
Why?
|
Protein Conformation | 1 | 2004 | 74 | 0.010 |
Why?
|
Cattle | 1 | 2004 | 127 | 0.010 |
Why?
|
In Vitro Techniques | 1 | 2004 | 176 | 0.010 |
Why?
|
Kinetics | 1 | 2004 | 194 | 0.010 |
Why?
|
Indicators and Reagents | 1 | 2003 | 12 | 0.010 |
Why?
|
Sodium | 1 | 2003 | 64 | 0.010 |
Why?
|
Thermodynamics | 1 | 2003 | 43 | 0.010 |
Why?
|
Fibroblasts | 1 | 2003 | 59 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2003 | 149 | 0.010 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2004 | 324 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2003 | 539 | 0.010 |
Why?
|